ARTV vs AVGO · $37.3M cap vs P/E 87, rev $41.50B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Broadcom Inc (AVGO) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
ARTV currently screens at market cap $37.3M. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
Not investment advice. Open the ARTV and AVGO stock pages for the full models.
Not investment advice.